Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001780713 | SCV002193512 | pathogenic | not provided | 2023-12-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu25Profs*65) in the CANT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CANT1 are known to be pathogenic (PMID: 19853239, 21037275, 22539336). This variant is present in population databases (rs763733217, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with CANT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1324008). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005014661 | SCV005653163 | likely pathogenic | Desbuquois dysplasia 1; Epiphyseal dysplasia, multiple, 7 | 2024-01-12 | criteria provided, single submitter | clinical testing |